Mumbai: For the first time in the country, anti-fibrotic drugs have been used to treat patients suffering from COVID-19-related lung fibrosis and breathlessness which has helped in the recovery of four such patients in Maharashtra's Pune, the Army has said."The researchers at the Pune-based Army Institute of Cardiothoracic Sciences (AICTS) have found this therapy very effective in this subset of COVID-19 patients and they were safely tolerated as well.
This is a novel strategy to tackle the lung fibrosis to treat subset of COVID-19 patients," the release said.It said these are early results and more research is being undertaken in this field to identify the patients who are likely to benefit from the therapy."Scientists have achieved a.